Wesleyan Assurance Society’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.18M | Buy |
10,500
+8,000
| +320% | +$6.23M | 0.53% | 48 |
|
|
2025
Q1 | $2.06M | Hold |
2,500
| – | – | 0.15% | 85 |
|
|
2024
Q4 | $1.93M | Hold |
2,500
| – | – | 0.15% | 85 |
|
|
2024
Q3 | $2.21M | Hold |
2,500
| – | – | 0.18% | 81 |
|
|
2024
Q2 | $2.27M | Hold |
2,500
| – | – | 0.2% | 78 |
|
|
2024
Q1 | $1.94M | Hold |
2,500
| – | – | 0.17% | 81 |
|
|
2023
Q4 | $1.46M | Hold |
2,500
| – | – | 0.14% | 87 |
|
|
2023
Q3 | $1.34M | Hold |
2,500
| – | – | 0.15% | 88 |
|
|
2023
Q2 | $1.17M | Hold |
2,500
| – | – | 0.13% | 88 |
|
|
2023
Q1 | $858K | Hold |
2,500
| – | – | 0.1% | 88 |
|
|
2022
Q4 | $914K | Hold |
2,500
| – | – | 0.11% | 88 |
|
|
2022
Q3 | $809K | Hold |
2,500
| – | – | 0.12% | 87 |
|
|
2022
Q2 | $811K | Hold |
2,500
| – | – | 0.12% | 87 |
|
|
2022
Q1 | $716K | Hold |
2,500
| – | – | 0.09% | 87 |
|
|
2021
Q4 | $690K | Hold |
2,500
| – | – | 0.08% | 87 |
|
|
2021
Q3 | $577K | Hold |
2,500
| – | – | 0.07% | 87 |
|
|
2021
Q2 | $574K | Hold |
2,500
| – | – | 0.07% | 85 |
|
|
2021
Q1 | $467K | Hold |
2,500
| – | – | 0.06% | 89 |
|
|
2020
Q4 | $422K | Hold |
2,500
| – | – | 0.06% | 89 |
|
|
2020
Q3 | $369K | Buy |
+2,500
| New | +$369K | 0.06% | 89 |
|
|
2020
Q2 | – | Sell |
-2,500
| Closed | -$346K | – | 92 |
|
|
2020
Q1 | $346K | Hold |
2,500
| – | – | 0.07% | 85 |
|
|
2019
Q4 | $328K | Hold |
2,500
| – | – | 0.06% | 79 |
|
|
2019
Q3 | $279K | Hold |
2,500
| – | – | 0.06% | 80 |
|
|
2019
Q2 | $277K | Hold |
2,500
| – | – | 0.05% | 80 |
|
|
2019
Q1 | $324K | Buy |
+2,500
| New | +$324K | 0.07% | 77 |
|